4 Followers on Owler

Delinia

is a biotechnology company that develops novel therapeutics for the treatment of autoimmune and inflammatory diseases... Read more
OverviewCompetitorsFundingNews & Insights

Delinia

is a biotechnology company that develops novel therapeutics for the treatment of autoimmune and inflammatory diseases... Read more
Delinia President & CEO: Saurabh Saha

President & CEO

Saurabh Saha

CEO Approval Rating

69/100

2015

PrivateSubsidiary of Celgene Corporation

Health Care Equipment & Services
Health Care Technology
8090 NAICS listing

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
100-250
Agree?
Funding
$35M

News

Jan 30, 2017
BioPortfolio
Delinia: Celgene to Acquire Autoimmune Disease Startup Delinia
Sep 15, 2016
FierceBiotechIT
Delinia: Sofinnova, Atlas lead next-gen autoimmune upstart's $35M Series A
Sep 14, 2016
PE Hub Network
Delinia: Delinia grabs $35 mln Series A

Delinia Competitors

1CalciMedica
2Alvine Pharmaceuticals
3Novoron Bioscience
4Opsona
5ChemoCentryx
6Ampio
7Xalud
8Sorrento
9Aurora Biomed
10Relay
Unlock 13 + competitors

Trending Companies